NB
AZN icon

Northwest Bancshares’s AstraZeneca AZN Stock Holding History

Northwest Bancshares’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,690
Closed -$228K – 203
2023
Q4 		$228K Sell
1,690
-33
-2% -$4.29K 0.04% 163
2023
Q3 		$233K Sell
1,723
-1
-0.1% -$137 0.04% 174
2023
Q2 		$247K Sell
1,724
-536
-24% -$78.9K 0.04% 170
2023
Q1 		$314K Sell
2,260
-98
-4% -$13.2K 0.06% 154
2022
Q4 		$320K Sell
2,358
-54
-2% -$6.77K 0.06% 150
2022
Q3 		$264K Sell
2,412
-77
-3% -$9.77K 0.06% 155
2022
Q2 		$329K Sell
2,489
-228
-8% -$29.9K 0.07% 144
2022
Q1 		$360K Sell
2,717
-46
-2% -$5.52K 0.07% 158
2021
Q4 		$322K Sell
2,763
-187
-6% -$22K 0.06% 171
2021
Q3 		$354K Sell
2,950
-112
-4% -$13K 0.08% 168
2021
Q2 		$367K Buy
3,062
+41
+1% +$4.5K 0.08% 165
2021
Q1 		$300K Sell
3,021
-75
-2% -$7.54K 0.07% 187
2020
Q4 		$309K Buy
3,096
+163
+6% +$17.3K 0.08% 170
2020
Q3 		$321K Sell
2,933
-513
-15% -$57.1K 0.08% 167
2020
Q2 		$364K Buy
+3,446
New +$356K 0.1% 157

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northwest Bancshares's AZN Position: Q1 2024 in Review

Northwest Bancshares sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 1,690 shares — an estimated $228K sold.

Northwest Bancshares first reported a position in AZN in Q2 2020 and held it in 15 quarters. The position peaked at $367K in Q2 2021. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Northwest Bancshares reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Northwest Bancshares sold 1,690 AstraZeneca shares in Q1 2024, an estimated $228K.
  • Northwest Bancshares first reported a position in AstraZeneca in Q2 2020 and held it in 15 quarters.
  • Northwest Bancshares's AstraZeneca position peaked at $367K in Q2 2021.
  • 1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Northwest Bancshares's 13F filing for Q1 2024, filed 26 Apr 2024.